Supportive Care News & Features
Patients prefer physicians who convey a more optimistic message, and perceive in them a higher level of compassion.
As key biologics near the end of their patent-protection periods, industry is preparing for legal battles over biosimilar versions.
Research highlights how lack of guidelines regarding illness and adequate staffing at hospitals may be reason for oncologists working while sick.
Patients enrolled in hospice care had lower rates of healthcare utilization, and their costs for care were less during their last year of life.
Poor health outcomes for many survivors, especially survivors of multiple myeloma, pancreatic cancer.
More in Supportive Care
ANAHEIM, CALIFORNIA—A multidisciplinary approach that also heavily incorporates input from patients and their families helped alleviate concerns about inappropriate use of palliative sedation and improved patient-centered care, a speaker said at the Oncology Nursing Society (ONS) 39th Annual Congress.
Inadequate pain management, baseline pain severity linked to pain deterioration
Duloxetine is effective in reducing pain in patients with painful chemotherapy-induced peripheral neuropathy, especially in those receiving drug as initial treatment.
A Canadian study has identified factors associated with opioid prescriptions for severe pain in the elderly: younger age, male sex, comorbid illness, type of cancer, and assessment at home, results of a study in the Journal of Clinical Oncology published online February 27 has found.
Intrathecal Therapy Cost-Effective for Patients with Cancer Pain Who Have a Favorable Life-Expectancy
In selected patients with cancer pain on high-cost conventional regimens, intrathecal therapy may become cost-effective as early as seven months following implant, and greater duration of therapy is associated with reduced costs.
Routine data collection and feedback at point-of-care improves most patient outcomes in hospice and palliative care.
A third of patients beginning palliative care die within a week.
Greatest risk of burnout in palliative care for younger doctors and those working more than 50 hours per week.
Palliative Care in Oncology Symposium: Limited time, support, and case management among barriers that hinder ability to provide palliative care.
Palliative Care in Oncology Symposium: Dispositional mindfulness may promote flourishing when confronting cancer.
For patients with breast cancer, use of the gonadotropin-releasing hormone agonist, goserelin, protects against ovarian failure.
Onset of sorafenib-associated hand-foot skin reactions can be delayed by urea-based cream plus best supportive care in advanced hepatocellular carcinoma.
Improvements in patient with advanced cancer in quality of life, reduction in psychological distress.
Hypercalcemia is one of the most common laboratory abnormalities in patients with cancer, and oncologists should know how to identify and treat it.
Non-Hodgkin lymphoma relapse is not a cause for increased anxiety if recurrence is quickly addressed with well tolerated therapy.
Sign Up for Free e-newsletters
Cancer Therapy Advisor Articles
- Body Mass Index Predicts Survival in Metastatic Clear Cell Renal Cell Carcinoma
- 4Kscore Might Reduce Unnecessary Prostate Biopsies
- Renal Cell Cancer: Keynote Lecture From GU Symposium 2015
- Disease Progression of Mantle Cell Lymphoma After Ibrutinib Associated with Poor Outcome
- Paclitaxel, Trastuzumab New Standard of Care for Early-Stage Breast Cancer
- Anticoagulants and Gastrointestinal Cancer Detection
- In Breast Cancer, Goserelin Protects Against Ovarian Failure
- Soligenix to Enroll Additional Subjects in SGX942 Trial for Oral Mucositis
- Cytarabine Plus Amonafide L-Malate Shows Similar Efficacy in Leukemia to Daunorubicin
- Correlated Spectroscopy Can Identify Changes in BRCA Carriers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|